» Articles » PMID: 14969756

M Cell Targeting by Lectins: a Strategy for Mucosal Vaccination and Drug Delivery

Overview
Specialty Pharmacology
Date 2004 Feb 19
PMID 14969756
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Bioadhesins are a recognised method of enhancing the absorption of drugs and vaccines at mucosal surfaces. Additionally, bioadhesins allow for cell specific targeting. Lectin-mediated targeting and delivery exploits unique surface carbohydrates on mucosal epithelial cells. The antigen-sampling M cells offer a portal for absorption of colloidal and particulate delivery vehicles, including bacteria, viruses and inert microparticles. We review work supporting the use of lectins to aid targeting to intestinal M cells. Consideration is also given to lectin-mediated targeting in non-intestinal sites and to the potential application of other bioadhesins to enhance M cell transport. While substantial hurdles must be overcome before mucosal bioadhesins can guarantee consistent, safe, effective mucosal delivery, this strategy offers novel opportunities for drug and vaccine formulation.

Citing Articles

Nanomedicine in the Treatment of Diabetes.

Andreadi A, Lodeserto P, Todaro F, Meloni M, Romano M, Minasi A Int J Mol Sci. 2024; 25(13).

PMID: 39000136 PMC: 11241380. DOI: 10.3390/ijms25137028.


Navigating Skin Delivery Horizon: An Innovative Approach in Pioneering Surface Modification of Ultradeformable Vesicles.

Nayak D, Rathnanand M, Tippavajhala V AAPS PharmSciTech. 2024; 25(5):126.

PMID: 38834910 DOI: 10.1208/s12249-024-02847-1.


Unlocking the Potential of Bilosomes and Modified Bilosomes: a Comprehensive Journey into Advanced Drug Delivery Trends.

Nayak D, Rathnanand M, Tippavajhala V AAPS PharmSciTech. 2023; 24(8):238.

PMID: 37989979 DOI: 10.1208/s12249-023-02696-4.


Targeting the Gut Mucosal Immune System Using Nanomaterials.

McCright J, Ramirez A, Amosu M, Sinha A, Bogseth A, Maisel K Pharmaceutics. 2021; 13(11).

PMID: 34834170 PMC: 8619927. DOI: 10.3390/pharmaceutics13111755.


Emerging Theranostic Nanomaterials in Diabetes and Its Complications.

Liu Y, Zeng S, Ji W, Yao H, Lin L, Cui H Adv Sci (Weinh). 2021; 9(3):e2102466.

PMID: 34825525 PMC: 8787437. DOI: 10.1002/advs.202102466.